PL2‐49, a monoclonal antibody against glycoprotein IIb which is a platelet activator
- 1 January 1989
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 71 (1), 57-63
- https://doi.org/10.1111/j.1365-2141.1989.tb06275.x
Abstract
PL2-49 is a murine monoclonal IgG1 antibody obtained after immunization of Balb/c mice with EDTA washed platelets. Binding could be detected on Zwa(+) as well as Zwa(—) platelets, but not on type I Glanzmann's thrombasthenia platelets using an ELISA screening test. Immunoprecipitation studies showed that PL2-49 bound to glycoprotein IIb when the glycoprotein IIb/IIIa complex dissociation was performed after the monoclonal antibody binding. Experiments with a human alloantibody against Zwa antigen were run in parallel to control the complex dissociation. Ascitic fluid, as well as the purified antibody, induced activation and aggregation of washed platelets and ATP release. PL2-49-induced aggregation did not require exogenous fibrinogen and was inhibited, partially, in the presence of aspirin, apyrase, isosorbide dinitrate. Raising intra-platelet cyclic AMP with a stable PGI2 analogue, iloprost, and/or a phosphodiesterase inhibitor, RA 233, suppressed the responses to PL2-49. F(ab')2 fragments did not induce aggregation of normal platelets but inhibited the response to the whole immunoglobulin. Finally PL2-49 was shown to induce aequorin-detected elevations in intraplatelet Ca++ levels. Thus PL2-49 seems to differ from monoclonal antibodies so far described, since it binds to glycoprotein IIb in a complex-dependent manner at least under our experimental conditions for immunoprecipitation studies, and it induces platelet Ca++ mobilization and platelet aggregation after a lag-time. These reactions depend both on Fab and Fc domains of the antibody and require neither complement nor exogenous fibrinogen.This publication has 26 references indexed in Scilit:
- Monoclonal antibodies against human platelet glycoprotein IIIaBritish Journal of Haematology, 2008
- Characterization of a monoclonal antibody ITI‐Pl 1 directed against human platelet membrane glycoprotein IIb using extracts of whole platelets and platelet surface and intracellular membranesBritish Journal of Haematology, 1988
- The platelet protein phosphorylation induced by a monoclonal antibody against human platelets (TP82)Biochemical and Biophysical Research Communications, 1985
- Lag-phase of arachidonic acid-induced secretion in responders and non-responders to thromboxane-synthetase inhibitors:Involvement of cyclic-AMPThrombosis Research, 1984
- Characteristics of platelet aggregation induced by the monoclonal antibody ALB6 (acute lymphoblastic leukemia antigen p 24)FEBS Letters, 1983
- A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa.JCI Insight, 1983
- Numbers of Receptor Sites from Scatchard Graphs: Facts and FantasiesScience, 1982
- Isolation and Quantitation of the Platelet Membrane Glycoprotein Deficient in Thrombasthenia Using a Monoclonal Hybridoma AntibodyJCI Insight, 1980
- Isolation and immunologic characterization of the human platelet alloantigen, P1A1Molecular Immunology, 1979
- THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONSAnnals of the New York Academy of Sciences, 1949